Clinical trial
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls
NCT01432847 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls
- Lead sponsor
- National Eye Institute (NEI)
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 7, 2011
- Completion date
- Not reported
- Enrollment
- 930 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amd, retinal degeneration, retinal disease, retinitis pigmentosa